Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.23 USD | -3.58% | -8.50% | +501.49% |
May. 31 | Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target | MT |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+501.49% | 176M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Wedbush Lowers Elevation Oncology's Price Target to $6 From $8, Updates Expectations Around Future Equity Raises; Keeps Outperform Rating